In the present study, patients with R‐type tumors expressing high CD44 in the tumor periphery of GBM showed the shortest survival time after Bev therapy, and the primary tumor showed a much more invasive type on MRI compared with patients with S‐type tumors (Figure S3). Here, CD44 is linked to glioblastoma.